Oxidative modification of low-density lipoprotein in relation to dyslipidemia and oxidant status in children with steroid sensitive nephrotic syndrome

Pediatric Research

Volumn 63, Issue 4, 2008, Pages 404-409

  El Melegy, Nagla T ^a,b   Mohamed, Nagwa A ^a   Sayed, Mohmed M ^a  

^a ASSIUT UNIVERSITY   (Egypt)

^b Assiut University Faculty of Medicine   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ASCORBIC ACID; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZING AGENT; PREDNISOLONE; RETINOL; TRIACYLGLYCEROL;

ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SENSITIVITY; DYSLIPIDEMIA; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; MONOTHERAPY; NEPHROTIC SYNDROME; OXIDATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN MODIFICATION; RECURRENT DISEASE; REMISSION; VITAMIN BLOOD LEVEL;

ANTIOXIDANTS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; NEPHROTIC SYNDROME; OXIDANTS; OXIDATIVE STRESS; RECURRENCE; SERUM ALBUMIN; STEROIDS;

EID: 41349113863     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181647af5     Document Type: Article

References (48)

1. Ece A, Atamer Y, Gurkan F, Davutoglu M, Kocyigit Y, Tutanc M 2005 Paraoxonase, total antioxidant response and peroxide levels in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 20:1279-1284
2. Kinra S, Rath B, Kabi BC 2000 Indirect quantification of lipid peroxidation in steroid responsive nephrotic syndrome. Arch Dis Child 82:76-78
3. Mathew JL, Kabi BC, Rath B 2002 Anti-oxidant vitamins and steroid responsive nephrotic syndrome in Indian children. J Paediatr Child Health 38:450-457
4. Ohtake T, Kumura M, Nishimura M, Hishida A 1997 Roles of reactive oxygen species and antioxidant enzymes in murine daunomycin induced nephropathy. J Lab Clin Med 129:81-88
5. Zima T, Tesar V, Stipek S 1997 The influence of cyclosporine on lipid peroxidation and superoxide dismutase in adriamycin nephropathy in rats. Nephron 75:464-469
6. Ece A, Atamer Y, Gurkan F, Bilici M, Kocyigit Y 2004 Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephritic syndrome. Nephrology 9:366-373
7. Kronenberg F 2005 Dyslipidemia and nephrotic syndrome: recent advances. J Ren Nutr 15:195-203
8. Merouani A, Levy E, Mongeau JG, Robitaille P, Lambert M, Delvin EE 2003 Hyperlipidemic profiles during remission in childhood idiopathic nephrotic syndrome. Clin Biochem 36:571-574
9. Vicca S, Massy ZA, Hennequin C, Rihane D, Nguyen-Khoa T, Drueke TB, Lacour B 2003 New insights into the effects of the protein moiety of oxidized LDL (oxLDL). Kidney Int Suppl 63:S125-S127
10. Verrotti A, Basciani F, Trotta D, Pomilio MP, Morgese G, Chiarelli F 2002 Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 y of sodium valproate and carbamazepine therapy. Epilepsy Res 48:71-75
11. Buege JA, Aust SD 1978 Microsomal lipid peroxidation. Methods Enzymol 52:302-310
12. Craig WY, Poulin SE, Nelson CP, Ritchie RF 1994 An ELISA method for the detection and quantization of IgG antibody against oxidized LDL: the effects of blocking buffer and the method of data expression on experimental findings. Clin Chem 40:882-888
13. Doumas BT, Walson WA, Biggs HG 1971 Albumin standards and the measurement of serum albumin with bromocresol green. Clin Chim Acta 31:87-96
14. Mills GC 1959 The purification and properties of glutathione peroxidase of erythrocyte. J Biol Chem 234:502-506
15. Hafeman DG, Sunde RA, Hockstka W 1974 Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J Nutr 104:580-587
16. Roe JH 1961 Standard Methods of Clinical Chemistry. Vol. III. Academic press, New York, pp 35
17. Nino HV, Parasad AS 1980 Vitamins and trace elements. In Sonnenwirth AC, Leonard J (eds) Gradwohl's Clinical Laboratory Methods and Diagnosis. 8th ed. Mosby Company, St. Louis, Missouri, pp 368
18. Baker SJ, Pereira SM, Begum A 1968 Failure of vitamin E therapy in the treatment of anemia of protein-calorie malnutrition. Blood 32:717-725
19. Assmann G, Jabs HV, Kohnert V, Nolte W, Schriewer H 1984 LDL-cholesterol determination in blood serum following precipitation of LDL with polyvinylsulfate. Clin Chim Acta 140:77-83
20. Grove TH 1979 Effect of reagent pH on determination of HDL-cholesterol by precipitation with sodium phosphotungestate-magnesium. Clin Chem 25:560-564
21. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC 1974 Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475
22. Bucolo G, David H 1973 Quantitative determination of serum triglycerides by use of enzymes. Clin Chem 19:476-482
23. Marcovina SM, Albers JJ, Dati F, Ledue TB, Richite RF 1991 International Federation of Clinical Chemistry Standardization Project for measurements of apo-A-I and B. Clin Chem 37:1676-1682
24. Imakita M, Yutani C, Strong JP, Sakurai I, Sumiyoshi A, Watanabe T, Mitsumata M, Kusumi Y, Katayama S, Mano M, Baba S, Mannami T, Tanaka K 2001 Second nation-wide study of atherosclerosis in infants, children and young adults in Japan. Atherosclerosis 155:487-497
25. Muntner P, Coresh J, Smith C, Eckfeldt J, Klag MJ 2000 Plasma lipids and risk of developing renal dysfunction. The atherosclerosis risk in communities study. Kidney Int 58:293-301
26. Delvin EE, Merouani A, Levy E 2003 Dyslipidemia in pediatric nephrotic syndrome: causes revisited. Clin Biochem 36:95-101
27. Diamond JR 1992 The role of reactive oxygen species in animal models of glomerular disease. Am J Kidney Dis 19:292-300
28. Fydryk J, Jacobson E, Kurzawska O, Malecka G, Gonet B, Urasiński T, Brodkiewicz A, Bukowska H 1998 Antioxidant status of children with steroid sensitive nephrotic syndrome. Pediatr Nephrol 12:751-754
29. Skrzep-Poloczek B, Tomasik A, Tarnawski R, Hyla-Klekot L, Dyduch A, Wojciechowska C, Wesolowski W, Kopieczna-Grzebieniak E, Zalejska-Fiolka J, Widera E 2001 Nephrotic origin hyperlipidemia, relative reduction of vitamin E level and subsequent oxidative stress may promote atherosclerosis. Nephron 89:68-72
30. Bayse CA, Baker RA, Ortwine KN 2005 Relative strengths of se...N,O interactions; Implications for glutathione peroxidase activity. Inorganica Chim Acta 358:3849-3854
31. Fydryk J, Olszewska M, Urasinski T, Brodkiewicz A 2003 Serum selenium level and glutathione peroxidase activity in steroid-sensitive nephrotic syndrome. Pediatr Nephrol 18:1063-1065
32. Abdel Ghany SM, Sobh MA, Al-Kareemy EA, Abdul-Nassar MA, Kilani AI 1992 Evaluations of changes in lipid profile and thyroid hormones in nephrotic syndrome. Assiut Med J 16:11-27
33. Kaysen GA, de Sain-van der Velden MG 1999 New insights into lipid metabolism in the nephrotic syndrome. Kidney Int Suppl 71:S18-S21
34. Shearer GC, Stevenson FT, Atkinson DN, Jones H, Staprans I, Kaysen GA 2001 Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome. Kidney Int 59:179-189
35. Kronenberg F, Lingenhel A, Lhotta K, Rantner B, Kronenberg MF, Konig P, Thiery J, Koch M, Von Eckardstein A, Dieplinger H 2004 Lipoprotein(a)- and LDL-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy? Kidney Int 66:348-354
36. Baxter JH, Goodman HC, Havel RJ 1960 Serum lipid and lipoprotein alterations in nephrosis. J Clin Invest 39:455-465
37. Vaziri ND, Liang K, Parks JS 2001 Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome. Am J Physiol Renal Physiol 280:F823-F828
38. Marsh JB, Welty FK, Lichtenstein AH, Lamon-Fava S, Schaefer EJ 2002 Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors. Atherosclerosis 162:227-244
39. Lee CM, Chien CT, Chang PY, Hsieh MY, Jui HY, Chau-Song Liau CS, Hsu SM, Lee YT 2005 HDL antagonizes oxidized LDL by suppressing oxygen free-radical formation and preserving nitric oxide bioactivity. Atherosclerosis 183:251-258
40. Yoshino G, Hirano T, Nagata K 1993 Hypertriglyceridemia in nephrotic rats is due to clearance defect of plasma triglyceride: overproduction of triglyceride-rich lipoprotein is not an obligatory factor. J Lipid Res 34:875-884
41. Kaysen GA, Pan XM, Couser WG, Staprans I 1993 Defective lipolysis persists in hearts of rats with heymann nephritis in the absence of nephrotic plasma. Am J Kidney Dis 22:128-134
42. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM 2004 Anti-inflammatory Properties of HDL. Circ Res 95:764-788
43. Nayak SS, Bhaskaranand N, Baliga M, Venkatesh A, Aroor AR 1988 Serum HDL-cholesterol and urinary cholesterol in nephrotic syndrome. Indian J Med Res 88:150-155
44. Zhang H, Huang WC, Tang SC 1994 (Serum apolipoprotein abnormalities in patients with idiopathic nephrotic syndrome). Zhonghua Yi Xue Za Zhi 74:542-544, 582-583
45. Kim BJ, Hwang ST, Sung KC, Kim BS, Kang JH, Lee MH, Park JR 2005 Comparison of the relationships between serum apolipoprotein B and serum lipid distributions. Clin Chem 51:2257-2263
46. Orzechowski A, Ostaszewski P, Wilczak J, Jank M, Balastinska B, Wareski P, Fuller JJ 2002 Rats with glucocorticoid-induced catabolic state show symptoms of oxidative stress and spleen atrophy: the effect of age and recovery. J Vet Med A Physiol Pathol Clin Med 49:256-263
47. Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, Matsumoto T 2003 Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 92:81-87
48. Kawamura T, Yoshioka T, Bills T, Fogo A, Ichikawa I 1991 Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries. Kidney Int 40:291-301